Chitosan Nanoparticles in Pulmonary Drug Delivery: Unleashing the Potential for Targeted and Effective Therapy
- 8 July 2026
- journal article
- review article
- Published by Wiley in Chemistry & Biodiversity
- Vol. 23 (7) , e71478
Abstract
Pulmonary drug delivery is used for local treatment of lung diseases and for systemic administration of drugs requiring rapid absorption. Drug delivery to the lungs is limited by mucociliary clearance, macrophage uptake, and short residence time of inhaled formulations. Polymer‐based carrier systems have therefore been explored to improve lung retention and delivery efficiency. Chitosan, a polysaccharide obtained from chitin, is biodegradable, biocompatible, and positively charged, enabling interaction with negatively charged pulmonary mucus. When formulated as nanoparticles, chitosan allows modulation of particle size, surface charge, and drug release behavior, which are critical parameters for pulmonary deposition. Chitosan nanoparticles have been investigated for delivery of small molecules, proteins, and nucleic acids in respiratory infections, inflammatory lung diseases, and lung cancer. Reported studies demonstrate improved lung localization and sustained drug release compared with conventional formulations. This review summarizes formulation approaches used for the preparation of chitosan nanoparticles for pulmonary delivery and discusses key physicochemical factors influencing their performance. Limitations related to aerosolization behavior and formulation reproducibility are also considered.Keywords
This publication has 56 references indexed in Scilit:
- Inhalable nanoparticle-based drug delivery system for non-small cell lung cancer therapy: promises and challengesSaudi Pharmaceutical Journal, 2025
- Opportunities for and Challenges of Pulmonary Drug Delivery in the Management of Acute Exacerbations of CNS DisordersCNS Drugs, 2025
- Recent Innovations Using Chitosan and Chitosan Derivatives‐Based Drug Delivery Systems for the Treatment of Pulmonary Diseases2024
- Nanomedicines for the Treatment of Systemic Candidiasis2023
- Development of a Novel Scaffold Based on Basil Seed Gum/Chitosan Hydrogel Containing Quercetin-Loaded Zein Microshphere for Bone Tissue EngineeringJournal of Polymers and the Environment, 2023
- An overview of anatomical and physiological aspects of the nose and the brain2021
- Comparative study of mucoadhesive and mucus-penetrative nanoparticles based on phospholipid complex to overcome the mucus barrier for inhaled delivery of baicaleinActa Pharmaceutica Sinica B, 2020
- Critical physicochemical attributes of chitosan nanoparticles admixed lactose-PEG 3000 microparticles in pulmonary inhalationAsian Journal of Pharmaceutical Sciences, 2020
- Alveolar Epithelium and Pulmonary Surfactant2016
- The suppression of lung tumorigenesis by aerosol-delivered folate–chitosan-graft-polyethylenimine/Akt1 shRNA complexes through the Akt signaling pathwayBiomaterials, 2009